Ulcerative colitis (UC) is a chronic, relapsing, and remitting inflammatory bowel disease (IBD) subtype affecting the rectum and colon.1 There are millions of IBD sufferers worldwide, with an increasing incidence worldwide.1-4 Active mucosal inflammation in UC results in diarrhoea, rectal bleeding, systemic effects, and in a minority can cause life-threatening sequelae.5-7 The recognition of the associated individual and societal health burdens has led to an increase in novel therapy...
